Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

Warning: foreach() argument must be of type array|object, null given in /var/www/wordpress/wp-content/themes/awaken-child/single-newsletter.php on line 54

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Treatment
  4. /
  5. Arenegyr

Arenegyr

April 12, 2017
Arenegyr
Trade Name
Orphan Indication Malignant pleural mesothelioma
USA Market Approval USA
USA Designation Date 2008-08-22 00:00:00
Sponsor MolMed S.p.A.;Via Olgettina 58;Milan

Related Treatment

  • Tazemetostat
  • Nivolumab and ipilimumab
  • Nivolumab
  • Cisplatin loaded hyaluronate film for implant
  • Doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modi
More Treatment
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2023 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo